Skip to main content

Table 1 Baseline characteristic of patients

From: Clinical efficacy of fecal microbiota transplantation for patients with small intestinal bacterial overgrowth: a randomized, placebo-controlled clinic study

  Overall FMT Placebo P value
N 55 28 27  
Age (mean ± SD) 40.3 ± 6.3 40.9 ± 7.4 39.7 ± 5.2 0.685
Weight (mean ± SD) 60.1 ± 3.9 59.2 ± 3.8 61.0 ± 4.0 0.833
Height (mean ± SD) 1.67 ± 0.07 1.69 ± 0.04 1.65 ± 3.98 0.734
BMI (mean ± SD) 21.7 ± 2.0 20.8 ± 1.6 22.5 ± 2.4 0.906
Male (%) 20(36.4) 10(35.7) 10(37.0) 0.906
Continue use of SIBO medication (%) 33(60.0) 17(60.7) 16(59.3) 0.579
Former tried SIBO medication (%) 42(76.4) 23(82.1) 19(70.4) 0.382
Former tried FODMAP diet (%) 26(47.3) 12(42.9) 14(51.9) 0.652
Born by casarean section (%) 7(12.7) 3(10.7) 4(14.8) 1
PPI (%) 9(16.4) 3(10.7) 6(22.2) 0.974
Antacid (%) 8(14.5) 4(14.3) 4(14.8) 0.523
Bile acid inhibitor (%) 5(9.1) 4(14.3) 1(3.7) 1
Immunosuppressor (%) 2(3.6) 1(3.6) 1(3.7) 1
  1. BMI, body mass index; SIBO, small intestinal bacterial overgrowth; PPI, proton pump inhibitor